Peer-reviewedCC BYFrontiers in reproductive health
Beyond the embryo: reframing recurrent implantation failure through immunopriming and endometrial immune dysregulation
- 1Reproductive Medicine, Nova WINGS IVF , ,
Related
- Persistently elevated estradiol after bilateral salpingo-oophorectomy in recurrent low-grade endometrial stromal sarcoma: a case report
- Treatment-Free Interval as a Prognostic Factor for Survival Outcomes in Patients with Advanced or Recurrent Endometrial Cancer Treated with Pembrolizumab Plus Lenvatinib: A Multi-Institutional Real-World Cohort Study
- Case Report: Sequential blastocyst transfer for women with unexplained recurrent implantation failure: a case series.
- PIK3CA Mutations in Advanced or Recurrent Endometrial Cancer: An Exploratory Molecular Profiling From the Phase II MITO END-3 Study.
- Lenvatinib starting doses below 20 mg versus 20 mg with pembrolizumab in advanced or recurrent endometrial cancer: a systematic review and meta-analysis of comparative observational evidence
BibTeX
@article{amin2026beyond,
title = {{Beyond the embryo: reframing recurrent implantation failure through immunopriming and endometrial immune dysregulation}},
author = {Jayesh Amin},
journal = {Frontiers in reproductive health},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13668873},
note = {CC BY},
}
RIS
TY - JOUR
TI - Beyond the embryo: reframing recurrent implantation failure through immunopriming and endometrial immune dysregulation
AU - Jayesh Amin
PY - 2026
DA - 2026/10/19
JO - Frontiers in reproductive health
UR - https://europepmc.org/article/PMC/PMC13668873
SN - 2673-3153
ER -